Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K954571Substantially Equivalent

Abusign Doa 3, Doa, Coc/thc/opi, Accusign Doa 3, Biosign Doa 3, Coc/thc/oopi

Princeton BioMeditech Corp., Monmouth Junction NJ / Traditional, Substantially Equivalent

K954571 is the FDA 510(k) clearance record for ABUSIGN DOA 3, DOA, COC/THC/OPI, ACCUSIGN DOA 3, BIOSIGN DOA 3, COC/THC/OOPI, a class II device, cleared for Princeton BioMeditech Corp. on under FDA product code DIO (Enzyme Immunoassay, Cocaine And Cocaine Metabolites). FDA records list 72 510(k) clearances for Princeton BioMeditech Corp., from to . As of , FDA records show no recalls naming K954571.

Clearance record

Decision date
Received
(32 days to decision)
Product code
DIO Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Regulation
21 CFR 862.3250
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Princeton BioMeditech Corp. 4242 U.S. Rt. 1, Monmouth Junction NJ
510(k) summary
Statement
Third party review
No

Clearances, product code DIO

Trailing 12 months

FDA records hold no clearances under product code DIO in the trailing twelve months.

FDA records show no clearances under product code DIO in the twelve months to November 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DIO, trailing twelve months
MonthClearances
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260
November 20260